Apnimed, Inc. (APMD)
29.00
+0.89
(+3.17%)
USD |
NASDAQ |
Sep 18, 16:00
29.40
+0.40
(+1.38%)
Pre-Market: 08:30
Apnimed Market Cap : 1.207B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.207B |
| September 17, 2026 | 1.170B |
| September 16, 2026 | 1.128B |
| September 15, 2026 | 1.064B |
| September 14, 2026 | 1.064B |
| September 11, 2026 | 1.092B |
| September 10, 2026 | 1.116B |
| September 09, 2026 | 1.169B |
| September 08, 2026 | 1.199B |
| September 04, 2026 | 1.143B |
| September 03, 2026 | 133.54M |
| September 02, 2026 | 1.108B |
| September 01, 2026 | 1.069B |
| August 31, 2026 | 1.045B |
| August 28, 2026 | 1.183B |
| August 27, 2026 | 1.144B |
| August 26, 2026 | 1.178B |
| August 25, 2026 | 1.090B |
| Date | Value |
|---|---|
| August 24, 2026 | 1.021B |
| August 21, 2026 | 1.116B |
| August 20, 2026 | 1.137B |
| August 19, 2026 | 1.276B |
| August 18, 2026 | 1.267B |
| August 17, 2026 | 1.296B |
| August 14, 2026 | 1.264B |
| August 13, 2026 | 1.147B |
| August 12, 2026 | 1.061B |
| August 11, 2026 | 990.40M |
| August 10, 2026 | 1.113B |
| August 07, 2026 | 1.075B |
| August 06, 2026 | 1.110B |
| August 05, 2026 | 1.056B |
| August 04, 2026 | 1.024B |
| August 03, 2026 | 995.58M |
| July 31, 2026 | 995.58M |
| July 30, 2026 | 637.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| IGC Pharma, Inc. | 29.19M |
| Cocrystal Pharma, Inc. | 16.68M |
| CNBX Pharmaceuticals, Inc. | 0.155M |
| GB Sciences, Inc. | 0.0814M |
| Arvinas, Inc. | 541.34M |
Market Cap Related Metrics
| PE Ratio | 12.41 |
| PS Ratio | 10.08 |
| Price | 29.00 |
| Earnings Yield | 8.06% |
| Operating PE Ratio | 50.71 |
| Normalized PE Ratio | 12.24 |